Navigation Links
New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases
Date:3/4/2015

PAOLI, Pa., March 4, 2015 /PRNewswire/ -- Results of the recent study, Results From a Set of 100 Consecutive Cases Using MarginProbe for Intra-Operative Positive Margin Detection, were presented as part of the general poster session at the 32nd Annual Miami Breast Cancer Conference last week.

The study, conducted by Moshe Papa, MD, FACS, Professor of Surgery at the Sackler School of Medicine at Tel Aviv University, reports an analysis of MarginProbe's efficiency and accuracy when used consecutively to examine excised breast tissue during a lumpectomy. The device was used in 100 consecutive lumpectomy procedures between June 2013 and October 2014. Last year, leading breast cancer national societies announced new guidelines for surgical outcomes that require bringing the patient back for a second procedure: "cancer on ink," according to pathology. According to these guidelines, 64 percent of such repeat procedures were spared by use of the MarginProbe in the study. Overall, eight patients underwent a re-excision lumpectomy procedure. Only three out of 100 patients underwent a re-excision procedure due to failed detection of the margins on the main specimen.   

"The fact that only three out of 100 patients had to undergo a re-excision procedure due to failed detection of cancer on the margins is impressive," said Dr. Papa. "The device was only used on the main specimen in this study so it would be interesting to do a study using MarginProbe on the shavings to determine if the total re-excision rate could be reduced even further."

"We are thrilled to present the results of yet another MarginProbe study that showcase its effectiveness in reducing the number of re-excisions," said Dan Hashimshony PhD, CEO and founder of Dune Medical Devices. "As we grow, and surgeons across the country continue to adopt MarginProbe, we become closer to our goal of drastically reducing repeat surgeries for women undergoing lumpectomies."

The study results were conclusive in determining that MarginProbe is an easy tool to use. When combined with intraoperative and clinical information from specimen radiology and palpitation, the majority of positive margins on the main specimen were identified and re-excision rates were reduced.

About Dune Medical Devices
Dune Medical Devices was founded in 2002 by Dr. Dan Hashimshony to realize the extraordinary medical potential of its proprietary tissue characterization technology. Offering surgeons and radiologists the real time ability to identify cancerous tissues and react immediately, this technology holds the promise for a broad range of surgical and diagnostic applications.

Dune Medical Devices is a privately held company with offices in the U.S. and Israel. For more information, please visit www.dunemedical.com.

Logo - http://photos.prnewswire.com/prnh/20150104/166834LOGO 
Logo - http://photos.prnewswire.com/prnh/20150104/166835LOGO 


'/>"/>
SOURCE Dune Medical Devices
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Advocacy Study Highlights Top Locations for High-Growth Companies
2. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
3. New Study Shows Full Spectrum Endoscopy Procedure Reduces The Miss Rate of Adenomas During Colonoscopy
4. Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak
5. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
6. Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S.
7. Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain
8. Ceregene Reports Additional Efficacy Data From Parkinsons Disease Phase 2b Study
9. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
10. Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency
11. Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/19/2019)... ... July 19, 2019 , ... ... D’OXYVA is a novel non-invasive transdermal (over-the-skin) technology, which is the leader in ... breadth of the clinical evidence obtained by Circularity over the past six years. ...
(Date:7/19/2019)... AGOURA HILLS, Calif. (PRWEB) , ... July 19, 2019 , ... ... Rhodes Levin, L.M.F.T., is proud to announce the expansion of The Missing Peace with ... Center for the Brain opens its doors July 19, 2019. , The ...
(Date:7/19/2019)... ... July 19, 2019 , ... Robinson Pharma, Inc., is proud to announce that ... audited by the Safe Quality Food (SQF) Institute using an accredited certification process and ... for Manufacturing, Edition 8. , The SQF Certification program is trusted by buyers around ...
Breaking Medicine Technology:
(Date:7/18/2019)... ... July 18, 2019 , ... We are pleased ... Texas Monthly Super Doctor Rising Star ! Each year, Texas Monthly ... trust for their own medical care. The Super Doctors research team then investigates ...
(Date:7/17/2019)... ... July 17, 2019 , ... ... Kentucky University’s online Family Nurse Practitioner program. The honor is given to distance ... education. , The Catalyst Awards honor institutions from around the world that ...
(Date:7/17/2019)... WATERLOO, Ontario (PRWEB) , ... July 17, 2019 ... ... case management software and client engagement options for human services providers worldwide, has ... California. , The CMAS program streamlines the procurement process for state and local ...
(Date:7/17/2019)... ... July 16, 2019 , ... A medical home care program found that having ... to better care for seniors. While this may not sound surprising, a recent two ... its Brandman Research Institute (BRI) uncovered several surprising outcomes based on a simple formatted ...
(Date:7/13/2019)... , ... July 12, 2019 , ... ... location in Clark County. The office is located at 5380 S. Rainbow Blvd., ... Hospital Medical Center. , The cancer center is equipped with state-of-the-art medical equipment ...
Breaking Medicine News(10 mins):